Participants with NAFLD showed significantly higher weight, BMI, waist circumference, MBP, plasma glucose, insulin, HOMA-IR, serum total cholesterol, AST and ALT levels, and lower proportion without chronic disease than participants without NAFLD in both men and women. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.